Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia

Avi Leader*, Anna Gurevich-Shapiro, Galia Spectre

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)S68-S73
Number of pages6
JournalThrombosis Research
Volume191
DOIs
Publication statusPublished - Jul 2020
Event10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) - Bergamo, Italy
Duration: 17 Apr 202019 Apr 2020

Keywords

  • Anticoagulation
  • Antiplatelet therapy
  • Atrial fibrillation
  • Cancer
  • Venous thromboembolism
  • Thrombocytopenia
  • ELEVATION MYOCARDIAL-INFARCTION
  • ACUTE CORONARY SYNDROME
  • PROPHYLACTIC PLATELET TRANSFUSIONS
  • RECURRENT VENOUS THROMBOEMBOLISM
  • HEMATOLOGIC MALIGNANCY PATIENTS
  • STEM-CELL-TRANSPLANTATION
  • MOLECULAR-WEIGHT HEPARIN
  • MARROW-TRANSPLANTATION
  • VENOOCCLUSIVE DISEASE
  • ATRIAL-FIBRILLATION

Cite this